BRIM Biotechnology Inc

ROCO:6885 (Taiwan)  
NT$ 31.45 (-1.72%) May 3
At Loss
P/B:
2.10
Market Cap:
NT$ 3.64B ($ 112.58M)
Enterprise V:
NT$ 1.95B ($ 60.26M)
Volume:
402.25K
Avg Vol (2M):
853.94K
Volume:
402.25K
At Loss
Avg Vol (2M):
853.94K

Business Description

Description
BRIM Biotechnology Inc applies integrated and efficient translational science to develop new treatments that help combat and cure disease. Its lead product candidate, BRM421, is on track to treat Dry Eye Syndrome (DES) which treats and repairs corneal damage. Its product help to treat Neurotrophic Keratitis, osteoarthritis, and corneal damage repair.
Name Current Vs Industry Vs History
Cash-To-Debt 472.06
Equity-to-Asset 0.98
Debt-to-EBITDA -0.01
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 50.76
Distress
Grey
Safe
Beneish M-Score 70.49
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 47.05
9-Day RSI 48.49
14-Day RSI 47.91
6-1 Month Momentum % -57.48
12-1 Month Momentum % -59.03

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 40.74
Quick Ratio 40.74
Cash Ratio 40.32

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -20.6
Shareholder Yield % -0.01

Profitability Rank

Name Current Vs Industry Vs History
Operating Margin % -771250
Net Margin % -764468.89
FCF Margin % -667323.33
ROE % -60.52
ROA % -58.98
ROIC % -847.46
ROC (Joel Greenblatt) % -9233.98
ROCE % -60.42

Financials

ROCO:6885's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

BRIM Biotechnology Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil NT$) 0.09
EPS (TTM) (NT$) -6.84
Beta 0
Volatility % 65.88
14-Day RSI 47.91
14-Day ATR (NT$) 1.378205
20-Day SMA (NT$) 31.1175
12-1 Month Momentum % -59.03
52-Week Range (NT$) 24.6 - 84.894858
Shares Outstanding (Mil) 115.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BRIM Biotechnology Inc Filings

Filing Date Document Date Form
No Filing Data

BRIM Biotechnology Inc Stock Events

Financials Calendars
Event Date Price(NT$)
No Event Data

BRIM Biotechnology Inc Frequently Asked Questions

What is BRIM Biotechnology Inc(ROCO:6885)'s stock price today?
The current price of ROCO:6885 is NT$31.45. The 52 week high of ROCO:6885 is NT$84.89 and 52 week low is NT$24.60.
When is next earnings date of BRIM Biotechnology Inc(ROCO:6885)?
The next earnings date of BRIM Biotechnology Inc(ROCO:6885) is .
Does BRIM Biotechnology Inc(ROCO:6885) pay dividends? If so, how much?
BRIM Biotechnology Inc(ROCO:6885) does not pay dividend.

Press Release

Subject Date
No Press Release